ASND · Ascendis Pharma A/S · Documents

$234.33 +4.38 (+1.90%) At close · Oct 20

Market Cap

$15.39B

65.80M

Volume · Oct 20 394.83K Avg daily vol (3M) 686.74K

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2022-05-02	—
6-K	—	2022-05-02	—
6-K	—	2022-04-13	—
6-K	—	2022-04-01	2022-03-31
6-K	—	2022-03-29	—
6-K	—	2022-03-14	—
6-K	—	2022-03-14	—
6-K	—	2022-03-09	2022-02-09
20-F	—	2022-03-02	2021-12-31
6-K	—	2022-03-02	—
6-K	—	2022-02-09	—
6-K	—	2022-01-13	—
6-K	—	2022-01-12	—
6-K	—	2022-01-10	—
6-K	—	2022-01-10	—
6-K	—	2022-01-04	—
6-K	—	2021-12-16	2021-12-15
6-K	—	2021-12-15	2021-12-14
6-K	—	2021-12-13	—
6-K	—	2021-11-18	—
6-K	—	2021-11-18	—
6-K	—	2021-11-12	—
6-K	—	2021-11-10	—
6-K	—	2021-11-10	2021-09-30
6-K	—	2021-11-10	—
6-K	—	2021-10-21	—
6-K	—	2021-10-15	—
6-K	—	2021-10-14	2021-10-13
6-K	—	2021-10-01	2021-09-30
6-K	—	2021-09-22	—
6-K	—	2021-09-16	2021-09-15
6-K	—	2021-09-07	—
6-K	—	2021-09-07	—
6-K	—	2021-08-27	2021-06-30
6-K	—	2021-08-26	2021-08-25
6-K	—	2021-08-26	2021-08-25
6-K	—	2021-08-12	—
6-K	—	2021-07-15	—
6-K	—	2021-07-06	—
6-K	—	2021-07-01	—
6-K	—	2021-06-14	2021-06-11
6-K	—	2021-06-14	—
6-K	—	2021-06-10	2021-06-09
6-K	—	2021-05-28	—
F-3ASR	—	2021-05-27	—
6-K	—	2021-05-27	—
6-K	—	2021-05-13	2021-05-12
6-K	—	2021-05-12	2021-05-11
6-K	—	2021-05-11	2021-05-10
6-K	—	2021-05-11	2021-05-10

Showing 201–250 of 299 filings

Key facts CIK 1612042 CUSIP K08588103 13F (30d) 32 filings 32 filers Visit website Investor relations